Mineralys Therapeutics In...
(MLYS)
undefined
undefined%
At close: undefined
11.90
0.59%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | - | - | - | - |
Cost of Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
Operating Income | -84.66M | -31.48M | -18.73M | -2.94M |
Interest Income | 12.76M | 1.68M | - | - |
Pretax Income | -71.90M | -29.80M | -19.41M | -3.43M |
Net Income | -71.90M | -29.80M | -19.41M | -3.43M |
Selling & General & Admin | 14.30M | 5.23M | 2.42M | 532.00K |
Research & Development | 70.36M | 26.25M | 16.31M | 2.41M |
Other Expenses | - | 4.00K | 1K | -1K |
Operating Expenses | 84.66M | 31.48M | 18.73M | 2.94M |
Interest Expense | - | 1.68M | 27.00K | 115.00K |
Selling & Marketing Expenses | - | - | - | - |
Cost & Expenses | 84.66M | 31.48M | 18.73M | 2.94M |
Income Tax | - | -1.90M | 27.00K | 115.00K |
Shares Outstanding (Basic) | 36.19M | 40.86M | 39.06M | 39.06M |
Shares Outstanding (Diluted) | 36.19M | 40.86M | 39.06M | 39.06M |
EPS (Basic) | -1.99 | -0.73 | -0.5 | -0.09 |
EPS (Diluted) | -1.99 | -0.73 | -0.5 | -0.09 |
EBITDA | -84.66M | -31.48M | - | - |
Depreciation & Amortization | - | 228.49K | 18.73M | 2.94M |